FDA Won't Add Black Box Warning To Blood Thinner Plavix
The U.S. Food and Drug Administration has shot down a 5-year-old request from Public Citizen to add a black box warning to Bristol-Myers Squibb and Sanofi-Aventis' blood thinner Plavix and its generic counterparts,...To view the full article, register now.
Already a subscriber? Click here to view full article